Is suPAR super as an ICU biomarker?; Novartis terminates aliskiren hypertension study;

> Is suPAR super? New biomarker for prediction, prognosis and even cause of problems in the ICU. Abstract

> Novartis' ($NVS) termination of aliskiren hypertension study may quash the idea of plasma renin activity as a high blood pressure biomarker. Article

> FDA follows Europe and clears heart disease predictive biomarker test for market. Release

> An alternative transcript variant of SLC39A14 could be new genetic biomarker for colorectal cancer. Abstract

> Researchers identify candidate biomarkers for Morquio syndrome. Abstract

> Plasma heat shock protein marks wasting in the elderly. Abstract

> Ovarian cancer biomarker diagnostic trial recruitment to conclude early after positive results. Article

> EF5 predicts response to cancer prodrugs. Abstract

> Molecular diagnostics company Vermillion acquires biomarker company Correlogic to expand its ovarian cancer franchise. Release

> Korean researchers use statistics to combine biomarkers for ovarian cancer test. Abstract

> Medscape Neurology on biomarkers at the ECTRIMS MS conference. Article

> GSK ($GSK) finds biomarkers for phase II cancer candidate. Abstract

> Alzheimer's Association International conference presentations discuss potential blood and CSF biomarkers for Alzheimer's disease. Article

> Lineagen and Fast Forward collaborate on MS biomarker-based diagnostic. Release

> Memorial University researcher gets Research & Development Corporation funding to discover biomarkers for detection and treatment of prostate cancer in Newfoundland and Labrador. Release

And Finally... CMAJ editorial ponders personalized medicine on behalf of the patient. Editorial